Research Article
Antiretroviral Resistance and Pregnancy Characteristics of Women with Perinatal and Nonperinatal HIV Infection
Figure 2
Antiretroviral drug resistance testing and therapy changes in women with perinatal and nonperinatal HIV infection. The proportion of women with a genotype collected and ARV resistance accounts for the number of participants eligible to have a genotype evaluated (HIV RNA viral load > 1,000 copies/mL). ARV resistance and multidrug resistance rates were significantly different between groups.